| Title: | The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naive healthy donors |
| Authors: | Mifsud, NA Illing, PT Ho, RBC Tuomisto, JE Fettke, H Mullan, KA McCluskey, J Rossjohn, J Vivian, J Reantragoon, R Purcell, AW |
| Issue Year: | 2023 |
| Publisher | WILEY |
| Series | ALLERGY: |
| Abstract | Allopurinol (ALP) is a successful drug used in the treatment of gout. However, this drug has been implicated in hypersensitivity reactions that can cause severe to life-threatening reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Individuals who carry the human leukocyte antigen (HLA)-B* 58:01 allotype are at higher risk of experiencing a hypersensitivity reaction (odds ratios ranging from 5.62 to 580.3 for mild to severe reactions, respectively). In addition to the parent drug, the metabolite oxypurinol (OXP) is implicated in triggering T cell-mediated immunopathology via a labile interaction with HLA-B* 58:01. To date, there has been limited information regarding the T-cell receptor (TCR) repertoire usage of reactive T cells in patients with ALP-induced SJS or TEN and, in particular, there are no reports examining paired alpha beta TCRs. Here, using in vitro drug-treated PBMCs isolated from both resolved ALP-induced SJS/TEN cases and drug-naive healthy donors, we show that OXP is the driver of CD8(+) T cell-mediated responses and that drug-exposed memory T cells can exhibit a proinflammatory immunophenotype similar to T cells described during active disease. Furthermore, this response supported the pharmacological interaction with immune receptors (p-i) concept by showcasing (i) the labile metabolite interaction with peptide/HLA complexes, (ii) immunogenic complex formation at the cell surface, and (iii) lack of requirement for antigen processing to elicit drug-induced T cell responsiveness. Examination of paired OXP-induced alpha beta TCR repertoires highlighted an oligoclonal and private clonotypic profile in both resolved ALP-induced SJS/ TEN cases and drug-naive healthy donors. |
| URI: | https://publications.svi.edu.au/publications/9175 |
| Other Identifiers | 10.1111/all.15814 |
| Publication type | Article |